Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
(ACTION Trial)
Recruiting in Palo Alto (17 mi)
+68 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Novo Nordisk A/S
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?
This trial is conducted in the United States of America (USA). The purpose of this study is to test whether biphasic insulin aspart 70/30 is a safe and at least as effective alternative in combination with two oral anti-diabetics compared to the two oral anti-diabetics alone for the control of blood glucose.
Research Team
GC
Global Clinical Registry (GCR, 1452)
Principal Investigator
Novo Nordisk A/S
Eligibility Criteria
Inclusion Criteria
Subjects with type 2 diabetes mellitu
Treatment Details
Interventions
- Anti-Diabetic Drugs (Other)
- Biphasic Insulin Aspart 70/30 (Insulin)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Novo Nordisk Investigational SiteTopeka, KS
Novo Nordisk Investigational SiteWichita, KS
Novo Nordisk Investigational SiteNorfolk, VA
Novo Nordisk Investigational SiteBaton Rouge, LA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Novo Nordisk A/S
Lead Sponsor
Trials
1578
Patients Recruited
3,813,000+